The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ASP3652 in First-in-Human and Ascending Multiple Oral Dose Studies in Healthy Subjects
Crossref DOI link: https://doi.org/10.1007/s12325-020-01402-1
Published Online: 2020-07-17
Published Print: 2020-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Takizawa, Masaomi
Cerneus, Dirk
Michon, Ingrid
Rijnders, Sanne
van der Heide, Desiree
Meijer, John
Stoelzel, Matthias
Sato, Yuichiro
Text and Data Mining valid from 2020-07-17
Version of Record valid from 2020-07-17
Article History
Received: 12 May 2020
First Online: 17 July 2020